Catalogo Articoli (Spogli Riviste)

OPAC HELP

Titolo:
Predictors of use of highly active antiretroviral therapy (HAART) among persons with AIDS in San Francisco, 1996-1999
Autore:
Hsu, LC; Vittinghoff, E; Katz, MH; Schwarcz, SK;
Indirizzi:
San Francisco Dept Publ Hlth, San Francisco, CA 94102 USA San Francisco Dept Publ Hlth San Francisco CA USA 94102 sco, CA 94102 USA Univ Calif San Francisco, Ctr AIDS Prevent Studies, San Francisco, CA 94143 USA Univ Calif San Francisco San Francisco CA USA 94143 ancisco, CA 94143 USA
Titolo Testata:
JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES
fascicolo: 4, volume: 28, anno: 2001,
pagine: 345 - 350
SICI:
1525-4135(200112)28:4<345:POUOHA>2.0.ZU;2-5
Fonte:
ISI
Lingua:
ENG
Soggetto:
IMMUNODEFICIENCY-VIRUS INFECTION; PROTEASE INHIBITOR USE; INJECTION-DRUG USERS; HIV-INFECTION; IMPACT; ZIDOVUDINE; SURVIVAL; DISEASE; SURVEILLANCE; PROGRESSION;
Keywords:
antiretroviral therapy; HAART; HIV; AIDS surveillance;
Tipo documento:
Article
Natura:
Periodico
Settore Disciplinare:
Clinical Medicine
Life Sciences
Citazioni:
43
Recensione:
Indirizzi per estratti:
Indirizzo: Hsu, LC San Francisco Dept Publ Hlth, 25 Van Ness Ave,Suite 500, San Francisco, CA94102 USA San Francisco Dept Publ Hlth 25 Van Ness Ave,Suite 500 San Francisco CA USA 94102
Citazione:
L.C. Hsu et al., "Predictors of use of highly active antiretroviral therapy (HAART) among persons with AIDS in San Francisco, 1996-1999", J ACQ IMM D, 28(4), 2001, pp. 345-350

Abstract

Highly active antiretroviral therapy (HAART) has contributed to a decreasein AIDS-related morbidity and mortality. This study used population-based AIDS surveillance data to evaluate the prevalence and predictors of HAART use among persons with AIDS in San Francisco. Use of HAART among persons living with AIDS increased from 41% in 1996 to 72% in 1999. Fourteen percent of persons diagnosed with AIDS between 1996 and 1999 initiated HAART before their AIDS diagnosis. Use of HAART before an AIDS diagnosis increased from 5% in 1996 to 26% in 1999. In the multivariable analysis, African Americans, injection drug users, and those without insurance at the time of AIDS diagnosis were less likely to use HAART before AIDS diagnosis. Delayed initiation of HAART after AIDS was more likely to occur among African Americans, injection drug users, homeless persons, those with public insurance, and those with higher CD4 counts. Although the overall prevalence of HAART use washigh, disparity in use of HAART existed by race and risk group, patient's insurance status, and facility of diagnosis. Barriers in use of treatment should be identified so all persons with AIDS can benefit from improved therapies.

ASDD Area Sistemi Dipartimentali e Documentali, Università di Bologna, Catalogo delle riviste ed altri periodici
Documento generato il 28/02/20 alle ore 12:04:10